Disk diffusion susceptibility test development for the new glycylcycline, GAR-936JONES, R. N.Diagnostic microbiology and infectious disease. 1999, Vol 35, Num 3, pp 249-252, issn 0732-8893Article

Summation : β-lactam resistance surveillance in the asia-western pacific regionJONES, R. N.Diagnostic microbiology and infectious disease. 1999, Vol 35, Num 4, pp 333-338, issn 0732-8893Article

Medium and supplement effects on the antimicrobial activity of quinupristin/dalfopristin tested by agar dilulation and etest methodsJONES, R. N.Diagnostic microbiology and infectious disease. 1996, Vol 26, Num 2, pp 99-102, issn 0732-8893Article

Isepamicin (SCH 21420, 1-N-HAPA gentamicin B) : microbiological characteristics including antimicrobial potency and spectrum of activityJONES, R. N.Journal of chemotherapy. 1995, Vol 7, pp 7-16, issn 1120-009X, SUP2Conference Paper

Asbestos exposures and thoracic neoplasmsJONES, R. N.Seminars in roentgenology. 1992, Vol 27, Num 2, pp 94-101, issn 0037-198XArticle

Broth-disk elution tests to predict the susceptibility of anaerobic bacteria to the ampicillin-sulbactam combinationJONES, R. N.Diagnostic microbiology and infectious disease. 1990, Vol 13, Num 4, pp 353-355, issn 0732-8893, 3 p.Article

In-vitro antimicrobial activity of enoxacin and its metabolitesJONES, R. N.Journal of antimicrobial chemotherapy (Print). 1989, Vol 23, Num 4, pp 658-660, issn 0305-7453Article

Rotatory dislocation of both atlanto-axial jointsJONES, R. N.Journal of bone and joint surgery. British volume. 1984, Vol 66, Num 1, pp 6-7, issn 0301-620XArticle

Can antimicrobial activity be sustained ? An appraisal of orally administered drugs used for respiratory tract infectionsJONES, R. N.Diagnostic microbiology and infectious disease. 1997, Vol 27, Num 1-2, pp 21-28, issn 0732-8893Conference Paper

Antimicrobial activity of Ro 41-1879, a new catechol cephalosporinJONES, R. N.Journal of chemotherapy. 1991, Vol 3, Num 6, pp 339-342Article

A New Reading of the Petra Temple InscriptionJONES, R. N.Bulletin of the American Schools of Oriental Research. 1989, Num 275, pp 41-46, issn 0003-097XArticle

Crush syndrome in a Cornish tin minerJONES, R. N.Injury. 1984, Vol 15, Num 4, pp 282-283, issn 0020-1383Article

Some Retrospective Thoughts on Vibrational SpectroscopyJONES, R. N.CAN. 1981, Vol 26, Num 1, pp 1-9Article

A Factor Analysis for the Counsellor Attitude ScaleJONES, R. N.British Journal of Guidance and Counselling Cambridge. 1977, Vol 5, Num 2, pp 185-188Article

In vitro evaluation of E-4695, a new fluoro-naphthyridineJONES, R. N.European journal of clinical microbiology & infectious diseases (Print). 1992, Vol 11, Num 2, pp 188-194, issn 0934-9723Article

The current and future impact of antimicrobial resistance among nosocomial bacterial pathogensJONES, R. N.Diagnostic microbiology and infectious disease. 1992, Vol 15, Num 2, pp 3S-10S, issn 0732-8893Conference Paper

Antimicrobial activity of Ro 24-6778, a covalent bonding of desmethylfleroxacin and desacetylcefotaximeJONES, R. N.Diagnostic microbiology and infectious disease. 1990, Vol 13, Num 3, pp 253-259, issn 0732-8893, 7 p.Article

Disk diffusion antimicrobial susceptibility testing of neisseria gonorrhoeaeJONES, R. N.Archives of dermatology (1960). 1990, Vol 126, Num 5, pp 577-578, issn 0003-987X, 2 p.Article

Review of cefotaxime sodium for surgical prophylaxis : a model for the evolution toward single-dose or short-course cost-effective regimensJONES, R. N.Diagnostic microbiology and infectious disease. 1990, Vol 13, Num 4, pp 317-327, issn 0732-8893, 11 p.Article

Should novobiocin be clinically re-evaluated?JONES, R. N.Diagnostic microbiology and infectious disease. 1989, Vol 12, Num 4, pp 363-365, issn 0732-8893Article

Microbiological conclusionsJONES, R. N.Drugs (Basel). 1991, Vol 42, pp 22-24, issn 0012-6667, SUP3Article

Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720) : a review of United States and Canadian resultsJONES, R. N.Diagnostic microbiology and infectious disease. 1991, Vol 14, Num 1, pp 37-43, issn 0732-8893, 7 p.Conference Paper

Preliminary in-vitro studies of BMY-28232, the active metabolite of the BMY-28271 cephalosporin esterJONES, R. N.Journal of antimicrobial chemotherapy (Print). 1989, Vol 23, Num 4, pp 654-657, issn 0305-7453Article

Cefmetazole (CS-1170), a new cephamycin with a decade of clinical experienceJONES, R. N.Diagnostic microbiology and infectious disease. 1989, Vol 12, Num 5, pp 367-379, issn 0732-8893Article

Effects of reduced cation supplement recommendations (national committee for clinical laboratory standards) on daptomycin Antistaphylococcal activityJONES, R. N.Antimicrobial agents and chemotherapy. 1989, Vol 33, Num 9, pp 1652-1653, issn 0066-4804Article